Recent advances in synthetic strategies of fourth-generation EGFR tyrosine kinase inhibitors under clinical trials for the treatment of resistant non-small cell lung cancer (NSCLC)

Bioorganic Chemistry 2026

View at publisher

Authors: Vaibhav Kadam, Harun Patel

DOI: 10.1016/j.bioorg.2026.110353

Cited by: 1

References: 38

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Lung Cancer Research Studies

References 38